In the fall of 2004, 29-year-old Avichai "Avi" Kremer, a first-semester MBA student at Harvard Business School, was diagnosed with ALS.
In May 2006, Prize4Life, along with the Harvard NeuroDiscovery Center organized a conference with top academic ALS researchers and high-level executives from the pharmaceutical and biotechnology industries.